Graham G. Walmsley
Insider CIK 1777517 · AKRO Director · OLMA Director · ALXO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2026-06-18 | 2026-06-23 | 29,500 | — | $0 | 29,500 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 93,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 1,200,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 9,398 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-10-08 | 2025-10-10 | 13,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-10-08 | 2025-10-10 | 15,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-10-08 | 2025-10-10 | 26,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-10-08 | 2025-10-10 | 23,832 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-10-08 | 2025-10-10 | 13,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-10-08 | 2025-10-10 | 23,832 | $19.97 | $475.9K | 93,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-10-08 | 2025-10-10 | 26,000 | $23.02 | $598.5K | 28,168 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-10-08 | 2025-10-10 | 15,000 | $8.13 | $122.0K | 43,168 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-10-08 | 2025-10-10 | 13,000 | $26.32 | $342.2K | 56,168 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-10-08 | 2025-10-10 | 13,000 | $25.20 | $327.6K | 69,168 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2025-06-11 | 2025-06-13 | 24,150 | — | $0 | 24,150 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2025-06-03 | 2025-06-05 | 9,398 | — | $0 | 11,566 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2025-03-27 | 2025-03-27 | 50,000 | $43.55 | $2.18M | 1,200,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2025-03-26 | 2025-03-27 | 58,691 | $43.01 | $2.52M | 1,150,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2025-03-25 | 2025-03-27 | 91,309 | $44.75 | $4.09M | 1,091,309 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2025-01-30 | 2025-02-07 | 200,000 | $48.00 | $9.60M | 1,000,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2024-12-17 | 2024-12-17 | 700,761 | $6.75 | $4.73M | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2024-12-17 | 2024-12-17 | 700,761 | $6.75 | $4.73M | 1,408,875 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2024-12-13 | 2024-12-18 | 700,761 | $6.75 | $4.73M | 700,761 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2024-12-13 | 2024-12-18 | 700,761 | $6.75 | $4.73M | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2024-06-14 | 2024-06-18 | 23,000 | — | $0 | 23,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2024-06-08 | 2024-06-11 | 26,000 | — | $0 | 26,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2024-06-04 | 2024-11-26 | 700,000 | $14.85 | $10.39M | 700,761 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2024-06-04 | 2024-11-26 | 475,000 | $14.85 | $7.05M | 708,114 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2024-06-04 | 2024-06-06 | 700,000 | $14.85 | $10.39M | 700,761 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2024-06-04 | 2024-06-06 | 475,000 | $14.85 | $7.05M | 708,114 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2023-12-08 | 2023-12-11 | 50,000 | $19.80 | $990.0K | 750,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2023-12-08 | 2023-12-11 | 50,000 | $19.85 | $992.5K | 800,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2023-12-05 | 2023-12-18 | 31,870 | $14.73 | $469.4K | 1,700,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2023-12-05 | 2023-12-18 | 50,000 | $14.95 | $747.5K | 1,750,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2023-12-05 | 2023-12-18 | 50,000 | $13.09 | $654.5K | 1,800,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2023-12-01 | 2023-12-05 | 50,000 | $16.99 | $849.5K | 700,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2023-11-30 | 2023-12-05 | 50,000 | $16.90 | $845.0K | 650,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2023-09-19 | 2023-05-23 | 400,000 | $26.00 | $10.40M | 400,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2023-09-12 | 2023-12-18 | 508,130 | $9.84 | $5.00M | 1,668,130 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2023-08-08 | 2023-08-10 | 25,000 | $42.06 | $1.05M | 600,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2023-08-01 | 2023-08-01 | 25,000 | $43.26 | $1.08M | 575,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2023-07-28 | 2023-08-01 | 30,000 | $42.69 | $1.28M | 550,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2023-06-23 | 2023-06-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2023-06-16 | 2023-06-21 | 21,520 | — | $0 | 21,520 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2023-05-19 | 2023-05-23 | 120,000 | $42.00 | $5.04M | 520,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2023-05-19 | 2023-06-15 | 120,000 | $42.00 | $5.04M | 520,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2022-09-19 | 2023-06-15 | 400,000 | $26.00 | $10.40M | 400,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2022-06-17 | 2022-06-27 | 21,520 | — | $0 | 21,520 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2022-06-16 | 2022-06-17 | 21,520 | — | $0 | 21,520 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2021-06-11 | 2021-06-15 | 12,004 | — | $0 | 12,004 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2021-06-09 | 2021-06-10 | 21,520 | — | $0 | 21,520 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | G Gift deriv | 2021-06-01 | 2021-06-03 | 23,832 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2021-06-01 | 2021-06-03 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | G Gift deriv | 2021-06-01 | 2021-06-03 | 13,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | G Gift deriv | 2021-06-01 | 2021-06-03 | 13,000 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-12-14 | 2020-12-15 | 20,000 | $76.00 | $1.52M | 995,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion deriv | 2020-11-23 | 2020-11-23 | 1,400,761 | — | $0 | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion deriv | 2020-11-23 | 2020-11-23 | 1,183,114 | — | $0 | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion | 2020-11-23 | 2020-11-23 | 1,400,761 | — | $0 | 1,400,761 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion | 2020-11-23 | 2020-11-23 | 1,183,114 | — | $0 | 1,183,114 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2020-11-23 | 2020-11-23 | 1,160,000 | $19.00 | $22.04M | 1,160,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2020-11-18 | 2020-11-19 | 21,520 | — | $0 | 21,520 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2020-11-18 | 2020-11-19 | 21,520 | — | $0 | 21,520 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2020-11-18 | 2020-11-19 | 21,520 | — | $0 | 21,520 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy deriv | 2020-09-30 | 2020-11-19 | 1,183,114 | $11.06 | $13.09M | 1,183,114 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 2,105,901 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-21 | 2,105,901 | — | $0 | 2,161,981 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-21 | 975,000 | $19.00 | $18.52M | 975,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2020-07-16 | 2020-07-17 | 24,009 | — | $0 | 24,009 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy deriv | 2020-06-01 | 2020-11-19 | 339,578 | $4.71 | $1.60M | 339,578 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy deriv | 2020-06-01 | 2020-11-20 | 339,578 | $4.71 | $1.60M | 1,400,761 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2020-06-01 | 2020-06-02 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2020-03-30 | 2020-04-01 | 2,168 | $19.97 | $43.3K | 2,168 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2019-11-08 | 2020-04-01 | 2,168 | — | $0 | 23,832 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2019-11-08 | 2019-11-12 | 26,000 | — | $0 | 26,000 | SEC↗ |